MotherToBaby

Medications and More during pregnancy and breastfeeding

Buscar

866.626.6847

Imipramine

Selected References:

  • Altshuler LL, et al. 1996. Pharmacologic Management of Psychiatric Illness during Pregnancy: Dilemmas and Guidelines. Am J Psychiatry, 153(5):592-606.
  • Ban L, et al. 2012. Live and Non-Live Pregnancy Outcomes among Women with Depression and Anxiety: A Population-Based Study. PLoS ONE, 7(8):e43462.
  • Bennet PN, The WHO Working Group. 1988. Drugs and Human Lactation. Elsevier, Amsterdam, New York, Oxford, pp. 289-290.
  • Committee on Drugs, American Academy of Pediatrics. 2001. The transfer of drugs and other chemicals into human breast milk. Pediatrics, 108:776-89.
  • Deligiannidis K, et al. 2014. A Review of Pharmacokinetic Changes and Clinical Recommendations for Therapeutic Drug Monitoring. J Clin Psychopharmacology, 34(2):244-255.
  • Desaunay P, et al. 2022. Neonatal hypotonia following in utero exposure to antidepressant drugs. J Pediatr, 245:222–226.e2.
  • Ericson A, et al. 1999. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol, 55:503-508.
  • Hemels MEH, et al. 2005. Antidepressant Use During Pregnancy and the Rates of Spontaneous Abortions: A Meta-Analysis. Ann Pharmacother, 39(5):803-809.
  • Horst PGJ, et al. 2011. Clomipramine concentration and withdrawal symptoms in 10 neonates. Br J Clin Pharmacol, 73(2):295-302.
  • Huybrechts KF, et al. 2015. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA, 313(21):2142-2151.
  • Larsen ER, et al. 2015. Use of psychotropic drugs during pregnancy and breastfeeding. Acta Psychiatr Scand, 132:1-28.
  • McElhatton PR, et al. 1996. The Outcome of Pregnancy in 689 Women Exposed to Therapeutic Doses of Antidepressants. A Collaborative Study of The European Network of Teratology Information Services (ENTIS)
  • Misri S, et al. 1991. Tricyclic drugs in pregnancy and lactation: a preliminary report. Int J Psychiatry Med, 21(2):157-171.
  • Mitchell JE, Popkin MK. 1983. Antidepressant drug therapy and sexual dysfunction in men: a review. J Clin Psychopharm, 3:76-79.
  • Nulman I, et al. 1997. Neurodevelopment of Children Exposed in Utero to Antidepressant Drugs. The New England Journal of Medicine, 336(4):258-262.
  • Nulman I, et al. 2002. Child Development Following Exposure to Tricyclic Antidepressant or Fluoxetine throughout Fetal Life: A Prospective, Controlled Study. Am J Psychiatry, 159(11):1889-1895.
  • Osborne LM, et al. 2014. Returning to tricyclic antidepressants for depression during childbearing: clinical and dosing challenges. Arch Womens Ment Health, 17:239-246.
  • Pearson KH, et al. 2007. Birth Outcomes Following Prenatal Exposure to Antidepressants. J Clin Psychiatry, 68(8):1284-1289.
  • Shah AA, et al. 2015. Are Psychotropic Drugs Safe to Use During Lactation? Psychiatric Annals, 45(2):77-82.
  • Shatan C, et al. 1966. Withdrawal Symptoms after Abrupt Termination of Imipramine. Canadian Psychiatric Association Journal, 11:150-158.
  • Uguz F, et al. 2014. Low-dose imipramine for treatment of panic disorder during pregnancy: a retrospective chart review. J Clin Psychopharmacol, 34(4):513-515.

MotherToBaby cuenta con el apoyo de la Administración de Recursos y Servicios de Salud (HRSA) del Departamento de Salud y Servicios Humanos de los Estados Unidos (HHS) como parte de una adjudicación por un total de $6,000,000 con cero porcentaje financiado con fuentes no gubernamentales. Los contenidos son los del autor/es y no representan necesariamente los puntos de vista oficiales de, ni un respaldo, por HRSA, HHS o el Gobierno de los Estados Unidos.